33 datasets found
  1. T

    Dianthus Therapeutics | MGTA - Stock Price | Live Quote | Historical Chart

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 9, 2018
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2018). Dianthus Therapeutics | MGTA - Stock Price | Live Quote | Historical Chart [Dataset]. https://tradingeconomics.com/mgta:us
    Explore at:
    csv, excel, json, xmlAvailable download formats
    Dataset updated
    Jun 9, 2018
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 2, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.

  2. Magenta Therapeutics, Inc. Alternative Data Analytics

    • meyka.com
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Meyka, Magenta Therapeutics, Inc. Alternative Data Analytics [Dataset]. https://meyka.com/stock/MGTA/alt-data/
    Explore at:
    Dataset provided by
    Description

    Non-traditional data signals from social media and employment platforms for MGTA stock analysis

  3. T

    Dianthus Therapeutics | MGTA - Market Capitalization

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Feb 25, 2020
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2020). Dianthus Therapeutics | MGTA - Market Capitalization [Dataset]. https://tradingeconomics.com/mgta:us:market-capitalization
    Explore at:
    csv, json, excel, xmlAvailable download formats
    Dataset updated
    Feb 25, 2020
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 3, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $1.27B in Market Capitalization this December of 2025, considering the latest stock price and the number of outstanding shares.Data for Dianthus Therapeutics | MGTA - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  4. T

    Dianthus Therapeutics | MGTA - Outstanding Shares

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Apr 15, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2024). Dianthus Therapeutics | MGTA - Outstanding Shares [Dataset]. https://tradingeconomics.com/mgta:us:outstanding-shares
    Explore at:
    excel, json, xml, csvAvailable download formats
    Dataset updated
    Apr 15, 2024
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 2, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported 29.35M in Outstanding Shares in April of 2024. Data for Dianthus Therapeutics | MGTA - Outstanding Shares including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  5. T

    Dianthus Therapeutics | MGTA - Employees Total Number

    • tradingeconomics.com
    csv, excel, json, xml
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS, Dianthus Therapeutics | MGTA - Employees Total Number [Dataset]. https://tradingeconomics.com/mgta:us:employees
    Explore at:
    csv, xml, json, excelAvailable download formats
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 2, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported 53 in Employees for its fiscal year ending in December of 2023. Data for Dianthus Therapeutics | MGTA - Employees Total Number including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  6. T

    Dianthus Therapeutics | MGTA - Assets

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Sep 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Dianthus Therapeutics | MGTA - Assets [Dataset]. https://tradingeconomics.com/mgta:us:assets
    Explore at:
    xml, csv, excel, jsonAvailable download formats
    Dataset updated
    Sep 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 2, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $577.44M in Assets for its fiscal quarter ending in September of 2025. Data for Dianthus Therapeutics | MGTA - Assets including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  7. T

    Dianthus Therapeutics | MGTA - Ordinary Share Capital

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Dec 15, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2024). Dianthus Therapeutics | MGTA - Ordinary Share Capital [Dataset]. https://tradingeconomics.com/mgta:us:ordinary-share-capital
    Explore at:
    json, xml, csv, excelAvailable download formats
    Dataset updated
    Dec 15, 2024
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 3, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $31K in Ordinary Share Capital for its fiscal quarter ending in December of 2024. Data for Dianthus Therapeutics | MGTA - Ordinary Share Capital including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  8. T

    Dianthus Therapeutics | MGTA - Current Assets

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Sep 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Dianthus Therapeutics | MGTA - Current Assets [Dataset]. https://tradingeconomics.com/mgta:us:current-assets
    Explore at:
    json, xml, csv, excelAvailable download formats
    Dataset updated
    Sep 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 2, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $413.82M in Current Assets for its fiscal quarter ending in September of 2025. Data for Dianthus Therapeutics | MGTA - Current Assets including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  9. T

    Dianthus Therapeutics | MGTA - Debt

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Dianthus Therapeutics | MGTA - Debt [Dataset]. https://tradingeconomics.com/mgta:us:debt
    Explore at:
    xml, json, excel, csvAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 2, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $1.33M in Debt for its fiscal quarter ending in June of 2025. Data for Dianthus Therapeutics | MGTA - Debt including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  10. T

    Dianthus Therapeutics | MGTA - Loan Capital

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Dec 15, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2024). Dianthus Therapeutics | MGTA - Loan Capital [Dataset]. https://tradingeconomics.com/mgta:us:loan-capital
    Explore at:
    excel, json, xml, csvAvailable download formats
    Dataset updated
    Dec 15, 2024
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 2, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in December of 2024. Data for Dianthus Therapeutics | MGTA - Loan Capital including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  11. T

    Dianthus Therapeutics | MGTA - Sales Revenues

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Dianthus Therapeutics | MGTA - Sales Revenues [Dataset]. https://tradingeconomics.com/mgta:us:sales
    Explore at:
    excel, json, csv, xmlAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 2, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $193K in Sales Revenues for its fiscal quarter ending in June of 2025. Data for Dianthus Therapeutics | MGTA - Sales Revenues including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  12. T

    Dianthus Therapeutics | MGTA - Equity Capital And Reserves

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Sep 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Dianthus Therapeutics | MGTA - Equity Capital And Reserves [Dataset]. https://tradingeconomics.com/mgta:us:equity-capital-and-reserves
    Explore at:
    csv, xml, excel, jsonAvailable download formats
    Dataset updated
    Sep 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 2, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $546.45M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025. Data for Dianthus Therapeutics | MGTA - Equity Capital And Reserves including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  13. T

    Dianthus Therapeutics | MGTA - Interest Income

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Dianthus Therapeutics | MGTA - Interest Income [Dataset]. https://tradingeconomics.com/mgta:us:interest-income
    Explore at:
    json, xml, excel, csvAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 2, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $3.4M in Interest Income for its fiscal quarter ending in June of 2025. Data for Dianthus Therapeutics | MGTA - Interest Income including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  14. T

    Dianthus Therapeutics | MGTA - EPS Earnings Per Share

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Dianthus Therapeutics | MGTA - EPS Earnings Per Share [Dataset]. https://tradingeconomics.com/mgta:us:eps
    Explore at:
    excel, json, csv, xmlAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 2, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $-0.88 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025. Data for Dianthus Therapeutics | MGTA - EPS Earnings Per Share including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  15. T

    Dianthus Therapeutics | MGTA - Operating Expenses

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Dianthus Therapeutics | MGTA - Operating Expenses [Dataset]. https://tradingeconomics.com/mgta:us:operating-expenses
    Explore at:
    json, xml, csv, excelAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 1, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $35.12M in Operating Expenses for its fiscal quarter ending in June of 2025. Data for Dianthus Therapeutics | MGTA - Operating Expenses including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  16. T

    Dianthus Therapeutics | MGTA - Ebitda

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Dianthus Therapeutics | MGTA - Ebitda [Dataset]. https://tradingeconomics.com/mgta:us:ebitda
    Explore at:
    csv, xml, excel, jsonAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 2, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $-34.83M in EBITDA for its fiscal quarter ending in June of 2025. Data for Dianthus Therapeutics | MGTA - Ebitda including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  17. T

    Dianthus Therapeutics | MGTA - Net Income

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Dianthus Therapeutics | MGTA - Net Income [Dataset]. https://tradingeconomics.com/mgta:us:net-income
    Explore at:
    excel, json, csv, xmlAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 2, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $-31.63M in Net Income for its fiscal quarter ending in June of 2025. Data for Dianthus Therapeutics | MGTA - Net Income including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  18. T

    Dianthus Therapeutics | MGTA - Trade Creditors

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Sep 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Dianthus Therapeutics | MGTA - Trade Creditors [Dataset]. https://tradingeconomics.com/mgta:us:trade-creditors
    Explore at:
    xml, json, csv, excelAvailable download formats
    Dataset updated
    Sep 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 1, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $6.7M in Trade Creditors for its fiscal quarter ending in September of 2025. Data for Dianthus Therapeutics | MGTA - Trade Creditors including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  19. T

    Dianthus Therapeutics | MGTA - Current Liabilities

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Sep 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Dianthus Therapeutics | MGTA - Current Liabilities [Dataset]. https://tradingeconomics.com/mgta:us:current-liabilities
    Explore at:
    excel, xml, json, csvAvailable download formats
    Dataset updated
    Sep 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 2, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $23.86M in Current Liabilities for its fiscal quarter ending in September of 2025. Data for Dianthus Therapeutics | MGTA - Current Liabilities including historical, tables and charts were last updated by Trading Economics this last December in 2025.

  20. T

    Dianthus Therapeutics | MGTA - Interest Expense On Debt

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Sep 15, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2024). Dianthus Therapeutics | MGTA - Interest Expense On Debt [Dataset]. https://tradingeconomics.com/mgta:us:interest-expense-on-debt
    Explore at:
    xml, excel, csv, jsonAvailable download formats
    Dataset updated
    Sep 15, 2024
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Dec 2, 2025
    Area covered
    United States
    Description

    Dianthus Therapeutics reported $4.44M in Interest Expense on Debt for its fiscal quarter ending in September of 2024. Data for Dianthus Therapeutics | MGTA - Interest Expense On Debt including historical, tables and charts were last updated by Trading Economics this last December in 2025.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
TRADING ECONOMICS (2018). Dianthus Therapeutics | MGTA - Stock Price | Live Quote | Historical Chart [Dataset]. https://tradingeconomics.com/mgta:us

Dianthus Therapeutics | MGTA - Stock Price | Live Quote | Historical Chart

Explore at:
csv, excel, json, xmlAvailable download formats
Dataset updated
Jun 9, 2018
Dataset authored and provided by
TRADING ECONOMICS
License

Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically

Time period covered
Jan 1, 2000 - Dec 2, 2025
Area covered
United States
Description

Dianthus Therapeutics stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.

Search
Clear search
Close search
Google apps
Main menu